Screening of Compounds for Anti-tuberculosis Activity, and in vitro and in vivo Evaluation of Potential Candidates
Tuberculosis (TB) is a debilitating infectious disease responsible for more than one million deaths per year. The emergence of drug-resistant TB poses an urgent need for the development of new anti-TB drugs. In this study, we screened a library of over 4,000 small molecules and found that orbifloxac...
Main Authors: | Wei Zhou, Bing Yang, Yanyan Zou, Khaista Rahman, Xiaojian Cao, Yingying Lei, Ren Lai, Zhen F. Fu, Xi Chen, Gang Cao |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2021-06-01
|
Series: | Frontiers in Microbiology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fmicb.2021.658637/full |
Similar Items
-
Rv3722c Promotes Mycobacterium tuberculosis Survival in Macrophages by Interacting With TRAF3
by: Yingying Lei, et al.
Published: (2021-02-01) -
Distinct Persistence Fate of <named-content content-type="genus-species">Mycobacterium tuberculosis</named-content> in Various Types of Cells
by: Xi Chen, et al.
Published: (2021-08-01) -
Conditional Silencing by CRISPRi Reveals the Role of DNA Gyrase in Formation of Drug-Tolerant Persister Population in Mycobacterium tuberculosis
by: Eira Choudhary, et al.
Published: (2019-03-01) -
Binding profile of protein–ligand inhibitor complex and structure based design of new potent compounds via computer-aided virtual screening
by: Gideon Adamu Shallangwa, et al.
Published: (2021-08-01) -
Development and Validation of a Microbiological Agar Assay for Determination of Orbifloxacin in Pharmaceutical Preparations
by: Hérida R. N. Salgado, et al.
Published: (2011-08-01)